Mealey's (September 13, 2019, 10:27 AM EDT) -- ALEXANDRIA, Va. — In a Sept. 9 final written decision, the Patent Trial and Appeal Board agreed with Illumina Inc. that two claims of a patent directed to a system for DNA sequencing would have been obvious to a person of skill in the art (POSITA) (Illumina Inc. v. The Trustees of Columbia University, No. IPR2018-00797, PTAB)....